The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
By A Mystery Man Writer
Description
New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
Soeun Park's research works Korea University, Seoul (KU) and other places
Cancers, Free Full-Text
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
Biomolecules, Free Full-Text
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances - ScienceDirect
NCT-58 - ZellBio GmbH
Cancers, Free Full-Text
NCT-58 (CAS Number: 2411429-33-7)
from
per adult (price varies by group size)